LG Chem
Clinical trials sponsored by LG Chem, explained in plain language.
A major South Korean chemical and pharmaceutical company, subsidiary of LG Corp.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
Can a daily capsule tame dangerous phosphorus levels in dialysis patients?
Disease control Recruiting nowThis study follows adults with chronic kidney disease who are on dialysis and starting the phosphate binder Nephoxil for high blood phosphorus. Researchers track patients for 48 weeks to see how many reach a target phosphorus level of 3.5 to 5.5 mg/dL, using either a low or stand…
Sponsor: LG Chem • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Monthly shot may pause early puberty in children
Disease control Recruiting nowThis study tests whether a monthly injection of leuprorelin, a drug that blocks puberty hormones, can safely slow or stop early puberty in children diagnosed with central precocious puberty. About 43 children—girls under 9 and boys under 10—will receive the injection every 4 week…
Phase 4 • Sponsor: LG Chem • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New drug combo aims to control advanced cancers
Disease control Recruiting nowThis early-phase study tests a new drug called LB-LR1109 in people with advanced solid tumors like lung, kidney, head and neck, bladder, or skin cancer that has not responded to standard treatments. The study first gives the drug alone, then in combination with another cancer dru…
Phase 1 • Sponsor: LG Chem • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC